1. Home
  2. ALGM vs TGTX Comparison

ALGM vs TGTX Comparison

Compare ALGM & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allegro MicroSystems Inc.

ALGM

Allegro MicroSystems Inc.

HOLD

Current Price

$45.98

Market Cap

9.3B

Sector

Technology

ML Signal

HOLD

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$55.57

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALGM
TGTX
Founded
1990
1993
Country
United States
United States
Employees
4250
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
8.5B
IPO Year
2007
2008

Fundamental Metrics

Financial Performance
Metric
ALGM
TGTX
Price
$45.98
$55.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
5
Target Price
$44.27
$49.80
AVG Volume (30 Days)
3.2M
2.1M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
79.49
1746.67
EPS
N/A
0.12
Revenue
$890,096,000.00
$2,785,000.00
Revenue This Year
$24.20
$49.08
Revenue Next Year
$17.94
$26.69
P/E Ratio
N/A
$462.50
Revenue Growth
22.77
N/A
52 Week Low
$22.41
$25.37
52 Week High
$71.77
$59.30

Technical Indicators

Market Signals
Indicator
ALGM
TGTX
Relative Strength Index (RSI) 41.39 56.49
Support Level $42.24 $28.57
Resistance Level $52.90 $58.34
Average True Range (ATR) 3.23 2.50
MACD -0.93 -0.68
Stochastic Oscillator 11.11 47.57

Price Performance

Historical Comparison
ALGM
TGTX

About ALGM Allegro MicroSystems Inc.

Allegro Microsystems Inc is a designer, developer, fabless manufacturer, and marketer of sensor ICs and application-specific analog power ICs for automotive and industrial markets. Its Sensor IC allows customers to precisely measure motion, speed, position, and current, and Power ICs include high-temperature and high-voltage capable motor drivers, power management, and LED driver ICs. Its products are divided into three categories: SENSE, which includes Current Sensors, Switches, and Latches, and Interface ICs among others; REGULATE, which includes Regulators, ClearPower Modules, and LED Drivers; and DRIVE, which includes BLDC Drivers, Brush DC, and others. Product-wise, the firm derives the majority of its revenue from sales of Magnetic sensors.

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

Share on Social Networks: